BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in VYGR — Voyager Therapeutics, Inc.
CIK 1107261
HOUSTON, TX
Position in VYGR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$337,591
-$6,122 QoQ
Shares Held
87,459
0.0% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $59,315,164 across 112 Biotechnology names. VYGR ranks #52 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
528,698 | $8,697,082 | |
| 2 | PBYI |
Puma Biotechnology, Inc.
|
775,341 | $4,954,428 | |
| 3 | EXEL |
Exelixis, Inc.
|
66,100 | $2,835,029 | |
| 4 | KROS |
Keros Therapeutics, Inc.
|
195,017 | $2,152,987 | |
| 5 | SGMT |
Sagimet Biosciences Inc.
|
299,641 | $1,565,624 | |
| 6 | BDTX |
Black Diamond Therapeutics, Inc.
|
723,477 | $1,541,006 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,498,860 | |
| 8 | KYTX |
Kyverna Therapeutics, Inc.
|
149,900 | $1,293,637 |
All Filings in VYGR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $337,591 | 87,459 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $343,713 | 87,459 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $408,433 | 87,459 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $349,747 | 112,459 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $543,027 | 160,659 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $284,101 | 50,106 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,082,887 | 185,109 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,446,193 | 182,831 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,673,668 | 179,771 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,525,918 | 180,796 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $784,731 | 101,781 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $620,864 | 101,781 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $602,543 | 101,781 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $512,875 | 86,781 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $661,271 | 86,781 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $99,676 | 36,781 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $478,347 | 181,881 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $645,519 | 156,300 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,245,036 | 264,339 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||